# Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring

> **NCT06668935** · — · RECRUITING · sponsor: **Abbott Diabetes Care** · enrollment: 800 (estimated)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** To utilize the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) to help prolong the length of time people with diabetes maintain adherence to GLP-1 and dual GIP/GLP-1 agonists

## Key facts

- **NCT ID:** NCT06668935
- **Lead sponsor:** Abbott Diabetes Care
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-24
- **Primary completion:** 2026-10
- **Final completion:** 2027-01
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2025-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06668935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06668935, "Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT06668935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*